IL17A and inflammatory response: Thus, IL-17 promotes eosinophilic airway inflammation by mounting Th2 responses during antigen sensitization while inhibiting eosinophilic airway inflammation by acting as a down-regulator of the dendritic cell-derived Th2 chemoattractant TARC during the effector phase [8,58].